<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0"><channel><title>Yahoo! Finance: OSTE News</title><copyright>Copyright (c) 2009 Yahoo! Inc. All rights reserved.</copyright><link>http://finance.yahoo.com/q/h?s=oste</link><description>Latest Financial News for Osteotech, Inc.</description><language>en-us</language><lastBuildDate>Thu, 17 Dec 2009 11:53:52 Etc/GMT</lastBuildDate><image><url>http://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gif</url><title>Yahoo! Finance</title><link>http://finance.yahoo.com</link><width>144</width><height>17</height></image><item><title>InPlay: Osteotech submits 510(k) application to FDA for clearance of its Duratech BioRegeneration Matrix (Briefing.com)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/mp#oste</link><description></description><guid isPermaLink="false">yahoo_finance/3550730722</guid><pubDate>Thu, 17 Dec 2009 11:53:52 Etc/GMT</pubDate></item><item><title>Osteotech Submits 510(k) Application to FDA for Clearance of its Duratech(TM) BioRegeneration Matrix (PR Newswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091217/ph27637.html?.v=1</link><description>Osteotech, Inc. , a leader in the emerging field of biologic products for regenerative healing, announced today that it has submitted a 510 application to the United States Food and Drug Administration to obtain marketing clearance for the use of its Duratech™ BioRegeneration Matrix to repair or replace the dura mater in various cranial surgical procedures.  This filing is based, in part, on data collected during the Company&apos;s human clinical study, which demonstrated the safety and performance of Duratech compared to currently marketed predicate dura substitute devices.  Based on available data, Osteotech estimates that the annual market for dura repair substitutes is approximately $100 million.  </description><guid isPermaLink="false">yahoo_finance/4215489608</guid><pubDate>Thu, 17 Dec 2009 11:30:00 Etc/GMT</pubDate></item><item><title>Osteotech&apos;s Plexur M(R) Innovative Grafting Now Approved for Use at 50 U.S. Hospitals (PR Newswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091201/ph18574.html?.v=1</link><description>Osteotech, Inc. , a leader in the emerging field of biologic products for regenerative healing, announced today that Plexur M® , a bone-polymer biocomposite built upon the Company&apos;s proprietary Plexur® technology platform, has been approved for use by 50 U.S. hospitals to date.</description><guid isPermaLink="false">yahoo_finance/3747792563</guid><pubDate>Tue, 1 Dec 2009 11:30:00 Etc/GMT</pubDate></item><item><title>OSTEOTECH INC Financials (EDGAR Online Financials)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/q/is?s=oste</link><description></description><guid isPermaLink="false">yahoo_finance/3258279731</guid><pubDate>Fri, 13 Nov 2009 14:05:38 Etc/GMT</pubDate></item><item><title>Osteotech Highlights Three Procedure-Specific MagniFuse(TM) Bone Grafting Products at the NASS 2009 Annual Meeting (PR Newswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091111/ph09265.html?.v=1</link><description>Osteotech, Inc. , a leader in the emerging field of biologic products for regenerative healing, today announced it is highlighting three procedure-specific MagniFuse bone grafting products for different spine therapy areas at the North American Spine Society 2009 Annual Meeting, taking place November 10th through 14th in San Francisco, California.</description><guid isPermaLink="false">yahoo_finance/2165524756</guid><pubDate>Wed, 11 Nov 2009 11:30:00 Etc/GMT</pubDate></item><item><title>OSTEOTECH INC Files SEC form 10-Q, Quarterly Report (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091109/oste10-q.html</link><description></description><guid isPermaLink="false">yahoo_finance/418360818</guid><pubDate>Mon, 9 Nov 2009 18:42:23 Etc/GMT</pubDate></item><item><title>CVR Energy, Osteotech: Biggest Price Decliners (CVI, OSTE) (at The Wall Street Journal Online)</title><link>http://us.rd.yahoo.com/finance/external/wsj/rss/SIG=12io3tlc1/*http%3A//online.wsj.com/article/SB10001424052748704795604574519992611131548.html?ru=yahoo&amp;mod=yahoo_hs</link><description></description><guid isPermaLink="false">yahoo_finance/1938677242</guid><pubDate>Fri, 6 Nov 2009 22:05:10 Etc/GMT</pubDate></item><item><title>OSTEOTECH INC Files SEC form 8-K, Results of Operations and Financial Condition (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091106/oste8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/4012872624</guid><pubDate>Fri, 6 Nov 2009 11:05:23 Etc/GMT</pubDate></item><item><title>Osteotech Reports Third Quarter 2009 Financial Results (PR Newswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091105/ph06432.html?.v=1</link><description>Osteotech, Inc. , a leader in the emerging field of biologic products for regenerative healing, today reported financial results for the third quarter ended September 30, 2009.</description><guid isPermaLink="false">yahoo_finance/1237758700</guid><pubDate>Fri, 6 Nov 2009 00:30:00 Etc/GMT</pubDate></item><item><title>Q3 2009 Osteotech Earnings Release - Time Not Supplied (CCBN)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/research/earncal/20091105.html?t=oste</link><description></description><guid isPermaLink="false">yahoo_finance/380577303</guid><pubDate>Thu, 5 Nov 2009 12:07:28 Etc/GMT</pubDate></item><item><title>OSTEOTECH INC Files SEC form 8-K, Entry into a Material Definitive Agreement (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091105/oste8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/1024047645</guid><pubDate>Thu, 5 Nov 2009 11:06:29 Etc/GMT</pubDate></item><item><title>Osteotech Secures 10-Year Tissue Supply Agreement (PR Newswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091104/ph04993.html?.v=1</link><description>Osteotech, Inc. , a leader in the emerging field of biologic products for regenerative healing, announced today that it entered into a multi-year tissue supply agreement with Community Tissue Services , with an initial term spanning 10 years.</description><guid isPermaLink="false">yahoo_finance/1145105357</guid><pubDate>Wed, 4 Nov 2009 11:30:00 Etc/GMT</pubDate></item><item><title>Osteotech Announces Third Quarter 2009 Financial Results Release and Conference Call (PR Newswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091030/ph02792.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/1597797428</guid><pubDate>Fri, 30 Oct 2009 21:19:00 Etc/GMT</pubDate></item><item><title>Osteotech&apos;s MagniFuse(TM) Technology Used in First U.S. Surgery (PR Newswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091028/ph00440.html?.v=1</link><description>Osteotech, Inc. , a leader in the emerging field of biologic products for regenerative healing, announced today that MagniFuse PC Bone Graft, a new tissue-based product built upon the Company&apos;s proprietary MagniFuse bone graft technology platform, has been used for the first time in a spinal surgery in the United States.</description><guid isPermaLink="false">yahoo_finance/3411855315</guid><pubDate>Wed, 28 Oct 2009 10:30:00 Etc/GMT</pubDate></item><item><title>OSTEOTECH INC Files SEC form 10-Q, Quarterly Report (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/090731/oste10-q.html</link><description></description><guid isPermaLink="false">yahoo_finance/3338207022</guid><pubDate>Fri, 31 Jul 2009 15:44:09 Etc/GMT</pubDate></item><item><title>OSTEOTECH INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/090730/oste8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/3209664438</guid><pubDate>Thu, 30 Jul 2009 10:05:09 Etc/GMT</pubDate></item><item><title>OSTEOTECH INC Files SEC form 10-Q, Quarterly Report (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/090507/oste10-q.html</link><description></description><guid isPermaLink="false">yahoo_finance/1744944719</guid><pubDate>Thu, 7 May 2009 20:11:20 Etc/GMT</pubDate></item><item><title>OSTEOTECH INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/090501/oste8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/1448056712</guid><pubDate>Fri, 1 May 2009 10:11:31 Etc/GMT</pubDate></item><item><title>OSTEOTECH INC Files SEC form 10-K, Annual Report (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/090316/oste10-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/2780698105</guid><pubDate>Mon, 16 Mar 2009 16:08:07 Etc/GMT</pubDate></item><item><title>Today&apos;s 5-Star Movers (at Motley Fool)</title><link>http://us.rd.yahoo.com/finance/external/mfool/rss/SIG=12fvketst/*http://www.fool.com/investing/general/2009/03/11/todays-five-star-movers.aspx?source=eptyholnk303100&amp;logvisit=y&amp;npu=y</link><description></description><guid isPermaLink="false">yahoo_finance/2630588679</guid><pubDate>Wed, 11 Mar 2009 16:21:37 Etc/GMT</pubDate></item></channel></rss><!-- c11.finance.sp2.yahoo.com compressed/chunked Thu Dec 17 05:28:09 PST 2009 -->
